Michelle E. Maglio
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
- Hematology 14
- Multiple Myeloma Research and Treatments 11
- Hematopoietic Stem Cell Transplantation 3
- Acute Myeloid Leukemia Research 2
- Oncology 6
- Peptidase Inhibition and Analysis 5
- Co-authors
- Paul Gerard Guy Richardson (10 shared papers)Jacob P. Laubach (7 shared papers)Cindy Varga (4 shared papers)Irene M. Ghobrial (3 shared papers)Robert Frank Cornell (2 shared papers)Javid J. Moslehi (2 shared papers)Constantine S. Mitsiades (3 shared papers)Kenneth Carl Anderson (4 shared papers)
- Journals
- British Journal of Haematology (3 papers)New England Journal of Medicine (2 papers)Blood (2 papers)Current Hematologic Malignancy Reports (1 paper)JAMA Oncology (1 paper)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Michelle E. Maglio
14 papers receiving 1.9k citations
Michelle E. Maglio's Hit Papers
Peers
Comparison fields: 5 of 63
- Hematology 1.6k
- Oncology 783
- Molecular Biology 1.1k
- Genetics 137
- Internal Medicine 18
Countries citing papers authored by Michelle E. Maglio
This map shows the geographic impact of Michelle E. Maglio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle E. Maglio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle E. Maglio more than expected).
Fields of papers citing papers by Michelle E. Maglio
This network shows the impact of papers produced by Michelle E. Maglio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle E. Maglio. The network helps show where Michelle E. Maglio may publish in the future.
Co-authors
The 25 scholars most cited alongside Michelle E. Maglio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma Hit paper breakdown → | 2017 | 977 |
| 2 | Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma Hit paper breakdown → | 2022 | 333 |
| 3 | 2014 | 168 | |
| 4 | 2016 | 79 | |
| 5 | 2012 | 72 | |
| 6 | 2015 | 69 | |
| 7 | 2012 | 67 | |
| 8 | 2018 | 42 | |
| 9 | 2018 | 28 | |
| 10 | 2016 | 27 | |
| 11 | 2017 | 22 | |
| 12 | 2011 | 9 | |
| 13 | 2014 | 7 | |
| 14 | 2014 | 1 |
About Michelle E. Maglio
Michelle E. Maglio is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Genetics, having authored 14 papers that have together received 1.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (11 papers), Protein Degradation and Inhibitors (6 papers), Peptidase Inhibition and Analysis (5 papers), Hematopoietic Stem Cell Transplantation (3 papers), Acute Myeloid Leukemia Research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Ubiquitin and proteasome pathways (2 papers) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Hematology (1.6k citations), Oncology (783 citations), Molecular Biology (1.1k citations), Genetics (137 citations) and Internal Medicine (18 citations). Michelle E. Maglio has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Paul Gerard Guy Richardson, Jacob P. Laubach, Cindy Varga, Irene M. Ghobrial, Robert Frank Cornell, Javid J. Moslehi, Constantine S. Mitsiades, Kenneth Carl Anderson, David Gailani and Weijuan Li. Their work appears in journals such as British Journal of Haematology, New England Journal of Medicine, Blood, Current Hematologic Malignancy Reports and JAMA Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.